東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Helicobacter pylori

Suzuki, Hidekazu.

FindBook

Google Book

Amazon

博客來

Helicobacter pylori

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Helicobacter pylori/ edited by Hidekazu Suzuki, Robin Warren, Barry Marshall.
其他作者:	Suzuki, Hidekazu.
出版者:	Tokyo :Springer Japan : : 2016.,
面頁冊數:	x, 267 p. :ill. (some col.), digital ;24 cm.
內容註:	Part I History -- Chapter 1 Brief History of the Discovery of Helicobacter Pylori -- Part II Pathogenesis -- Chapter 2 Human Migration -- Chapter 3 CagA -- Chapter 4 Helicobacter Pylori VacA Exhibits Pleiotropic Actions in Host Cells -- Chapter 5 Autophagy -- Chapter 6 Ghrelin and Gut Hormone -- Chapter 7 Symptom Generation -- Chapter 8 Gastric Non-Helicobacter Pylori Helicobacter: It's Significance in Human Gastric Diseases -- Part III Diagnosis -- Chapter 9 Urea Breath Test & Rapid Urease Test -- Chapter 10 Endoscopic Findings of H. Pylori Infection -- Chapter 11 Gastric Cancer Risk stratification by H. pylori -- Chapter 12 Prevention of Gastric Cancer by Helicobacter Pylori Eradication: Current Evidence and Future Prospects -- Part IV Treatment -- Chapter 13 Trends in Global Eradication Rates -- Chapter 14 Personalized Therapy in H. Pylori Eradication -- Chapter 15 Quadruple Regimens for Helicobacter Pylori Infection -- Chapter 16 Third-Line Eradication Therapy.
Contained By:	Springer eBooks
標題:	Helicobacter pylori. -
電子資源:	http://dx.doi.org/10.1007/978-4-431-55705-0
ISBN:	9784431557050

Helicobacter pylori
Helicobacter pylori[electronic resource] /edited by Hidekazu Suzuki, Robin Warren, Barry Marshall. - Tokyo :Springer Japan :2016. - x, 267 p. :ill. (some col.), digital ;24 cm.

Part I History -- Chapter 1 Brief History of the Discovery of Helicobacter Pylori -- Part II Pathogenesis -- Chapter 2 Human Migration -- Chapter 3 CagA -- Chapter 4 Helicobacter Pylori VacA Exhibits Pleiotropic Actions in Host Cells -- Chapter 5 Autophagy -- Chapter 6 Ghrelin and Gut Hormone -- Chapter 7 Symptom Generation -- Chapter 8 Gastric Non-Helicobacter Pylori Helicobacter: It's Significance in Human Gastric Diseases -- Part III Diagnosis -- Chapter 9 Urea Breath Test & Rapid Urease Test -- Chapter 10 Endoscopic Findings of H. Pylori Infection -- Chapter 11 Gastric Cancer Risk stratification by H. pylori -- Chapter 12 Prevention of Gastric Cancer by Helicobacter Pylori Eradication: Current Evidence and Future Prospects -- Part IV Treatment -- Chapter 13 Trends in Global Eradication Rates -- Chapter 14 Personalized Therapy in H. Pylori Eradication -- Chapter 15 Quadruple Regimens for Helicobacter Pylori Infection -- Chapter 16 Third-Line Eradication Therapy.

This book provides a detailed review of the most recent pathogenetic, diagnostic and therapeutic approaches in connection with Helicobacter pylori, along with priority areas in research and trends in clinical practice to address this significant pathogen acknowledged as the causative agent in a wide range of diseases, including gastric adenocarcinoma, MALT lymphoma and immune thrombocytopenic purpura (ITP) Medical authorities worldwide now recommend a "test and treat" strategy for this bacterial infection. Eradication therapy approaches range from general mass eradication therapy to tailor-made therapy for antibiotic-resistant refractory infection. In regions with high prevalence of H. pylori infection, the infection itself would be considered a major parameter to predict the risk of gastric adenocarcinoma development. The main interest has shifted recently to the risk stratification strategy for gastric cancer development and to the wide-ranging application of its serological prevention program. This book will benefit all gastroenterologists, hematologists, dermatologists, primary care doctors, epidemiologists, physicians who related with community hygiene, as well as basic scientists, particularly microbiologists, bacteriologists, pathologists, molecular biologists, biochemists, immunologists and oncologists.

ISBN: 9784431557050

Standard No.: 10.1007/978-4-431-55705-0doiSubjects--Topical Terms:

2191945
Helicobacter pylori.

LC Class. No.: QR201.H44

Dewey Class. No.: 616.92

Helicobacter pylori
LDR:03245nmm a2200313 a 4500 001 2036082
003 DE-He213
005 20160930114659.0
006 m d
007 cr nn 008maaau
008 161117s2016 ja s 0 eng d
020 $a 9784431557050 $q (electronic bk.)
020 $a 9784431557043 $q (paper)
024 7 $a 10.1007/978-4-431-55705-0 $2 doi
035 $a 978-4-431-55705-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QR201.H44
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
082 0 4 $a 616.92 $2 23
090 $a QR201.H44 $b H475 2016
245 0 0 $a Helicobacter pylori $h [electronic resource] / $c edited by Hidekazu Suzuki, Robin Warren, Barry Marshall.
260 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a x, 267 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I History -- Chapter 1 Brief History of the Discovery of Helicobacter Pylori -- Part II Pathogenesis -- Chapter 2 Human Migration -- Chapter 3 CagA -- Chapter 4 Helicobacter Pylori VacA Exhibits Pleiotropic Actions in Host Cells -- Chapter 5 Autophagy -- Chapter 6 Ghrelin and Gut Hormone -- Chapter 7 Symptom Generation -- Chapter 8 Gastric Non-Helicobacter Pylori Helicobacter: It's Significance in Human Gastric Diseases -- Part III Diagnosis -- Chapter 9 Urea Breath Test & Rapid Urease Test -- Chapter 10 Endoscopic Findings of H. Pylori Infection -- Chapter 11 Gastric Cancer Risk stratification by H. pylori -- Chapter 12 Prevention of Gastric Cancer by Helicobacter Pylori Eradication: Current Evidence and Future Prospects -- Part IV Treatment -- Chapter 13 Trends in Global Eradication Rates -- Chapter 14 Personalized Therapy in H. Pylori Eradication -- Chapter 15 Quadruple Regimens for Helicobacter Pylori Infection -- Chapter 16 Third-Line Eradication Therapy.
520 $a This book provides a detailed review of the most recent pathogenetic, diagnostic and therapeutic approaches in connection with Helicobacter pylori, along with priority areas in research and trends in clinical practice to address this significant pathogen acknowledged as the causative agent in a wide range of diseases, including gastric adenocarcinoma, MALT lymphoma and immune thrombocytopenic purpura (ITP) Medical authorities worldwide now recommend a "test and treat" strategy for this bacterial infection. Eradication therapy approaches range from general mass eradication therapy to tailor-made therapy for antibiotic-resistant refractory infection. In regions with high prevalence of H. pylori infection, the infection itself would be considered a major parameter to predict the risk of gastric adenocarcinoma development. The main interest has shifted recently to the risk stratification strategy for gastric cancer development and to the wide-ranging application of its serological prevention program. This book will benefit all gastroenterologists, hematologists, dermatologists, primary care doctors, epidemiologists, physicians who related with community hygiene, as well as basic scientists, particularly microbiologists, bacteriologists, pathologists, molecular biologists, biochemists, immunologists and oncologists.
650 0 $a Helicobacter pylori. $3 2191945
650 0 $a Helicobacter pylori infections. $3 2191946
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Gastroenterology. $3 828956
650 2 4 $a Pathology. $3 643180
650 2 4 $a Hematology. $3 808260
700 1 $a Suzuki, Hidekazu. $3 2191942
700 1 $a Warren, Robin. $3 2191943
700 1 $a Marshall, Barry. $3 2191944
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55705-0
950 $a Medicine (Springer-11650)